Researchmoz added Most up-to-date research on "United
States Biopsy
Market, Volume & Forecast by Segments (Breast, Prostate,
Lung, Liver & Thyroid) & Companies" to its huge
collection of research reports. An insight on the important factors
and trends influencing the market.
Latest Research report titled “United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver and Thyroid), Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, FUJIFILM Holdings Corporation, Medtronic plc., Hologic, Inc)” provides a complete analysis of the United States Biopsy Market and Volume.
United States Biopsy Market will cross US$ 17 Billion by the year 2024 owing to the rising prevalence of cancer in the region. According to the World Health Organization, cancer cases are expected to surge 57% worldwide in the next 20 years. Biopsies are most often done to look for cancer; a biopsy is a sample of tissue taken from the body in order to examine it more closely. Further, growing patient awareness and the advancement in the biopsy techniques are also expected to fuel future growth of biopsy market in United States.
The World Cancer Report, produced by the WHO's specialized cancer agency and released on World Cancer Day, predicts new cancer cases will rise from an estimated 14 million annually in 2012 to 22 million within two decades. Over the same period, cancer deaths are predicted to rise from 8.2 million a year to 13 million.
Request Sample Pages Of This Premium Research Report: https://www.researchmoz.us/enquiry.php?type=S&repid=1572616
By Segment – United States Biopsy Market and Volume
On segment basis, Breast cancer biopsies accounts for the highest share in the United States Biopsy Market for the year 2017. While, in terms of Volume, Breast cancer biopsy has second highest share. Further, the report also covers the market aspects of Liver, Lung and Thyroid cancer biopsies. The Unites States Biopsy Market and Volume will experience a major growth during the forecast period owing to the increasing number of biopsy procedures and rising demand for minimally invasive procedures
All the 8 companies studied in the report have been studied from 4 points
- Overview
- Business Strategy-
- Merger & Acquisition-
- Financial Insight
This 108 page report with 28 Figures and 2 Tables provides a complete analysis of the key Growth Drivers and Challenges, market, and their projections for the upcoming years.
Segments Covered in the Report:
- Breast Cancer Biopsy
- Prostate Cancer Biopsy
- Lung Cancer Biopsy
- Liver Cancer Biopsy
- Thyroid Cancer Biopsy
Key Companies Covered in the Report:
- C. R. Bard, Inc.
- Becton, Dickinson and Company
- B. Braun Melsungen AG
- Cardinal Health, Inc.
- Olympus Corporation
- FUJIFILM Holdings Corporation
- Medtronic plc.
- Hologic, Inc
United States – Biopsy Testing Market – Overview
United States Biopsy Test Market was more than US$ 15 Billion in 2014 and future seems to be much brighter. In the United States Biopsy Test Market, Breast Cancer is the most popular segment in 2014. Thyroid cancer stands at the last spot, but it is the most rapidly increasing type of cancer in the United States. However if we make the analysis from the Volume point then Prostate Cancer is the most popular segment. Increasing United States prevalence of cancer, geriatric population and increasing demand for minimally invasive procedures are expected to drive market growth during the forecast period.
Place an Enquiry to Our Industry Expert at @ https://www.researchmoz.us/enquiry.php?type=E&repid=1572616
(*Fill the form and our sales representative will get back to you for assistance)
Latest Research report titled “United States – Biopsy Testing Market & Volume Analysis to 2020” provides a comprehensive assessment of the fast–evolving, high–growth of Biopsy Market. This 53 page report with 28 Figures and 1 Table analyses the United States Biopsy Test Market and Volume by 5 Top Cancer Segment, driving factors and challenges for Biopsy market.
The United States Biopsy Market has been analyzed from two view points
- United States Biopy Test Market & Forecast (2008 – 2020)
- United States Biopy Test Volume & Forecast (2008 – 2020)
The Top 5 Cancer Segments covered are:
- Breast Cancer
- Prostate Cancer
- Liver Cancer
- Lung Cancer
- Thyroid Cancer
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
For More Reports Visit @ http://marketresearchlatestreports.blogspot.com/
Latest Research report titled “United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver and Thyroid), Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, FUJIFILM Holdings Corporation, Medtronic plc., Hologic, Inc)” provides a complete analysis of the United States Biopsy Market and Volume.
United States Biopsy Market will cross US$ 17 Billion by the year 2024 owing to the rising prevalence of cancer in the region. According to the World Health Organization, cancer cases are expected to surge 57% worldwide in the next 20 years. Biopsies are most often done to look for cancer; a biopsy is a sample of tissue taken from the body in order to examine it more closely. Further, growing patient awareness and the advancement in the biopsy techniques are also expected to fuel future growth of biopsy market in United States.
The World Cancer Report, produced by the WHO's specialized cancer agency and released on World Cancer Day, predicts new cancer cases will rise from an estimated 14 million annually in 2012 to 22 million within two decades. Over the same period, cancer deaths are predicted to rise from 8.2 million a year to 13 million.
Request Sample Pages Of This Premium Research Report: https://www.researchmoz.us/enquiry.php?type=S&repid=1572616
By Segment – United States Biopsy Market and Volume
On segment basis, Breast cancer biopsies accounts for the highest share in the United States Biopsy Market for the year 2017. While, in terms of Volume, Breast cancer biopsy has second highest share. Further, the report also covers the market aspects of Liver, Lung and Thyroid cancer biopsies. The Unites States Biopsy Market and Volume will experience a major growth during the forecast period owing to the increasing number of biopsy procedures and rising demand for minimally invasive procedures
All the 8 companies studied in the report have been studied from 4 points
- Overview
- Business Strategy-
- Merger & Acquisition-
- Financial Insight
This 108 page report with 28 Figures and 2 Tables provides a complete analysis of the key Growth Drivers and Challenges, market, and their projections for the upcoming years.
Segments Covered in the Report:
- Breast Cancer Biopsy
- Prostate Cancer Biopsy
- Lung Cancer Biopsy
- Liver Cancer Biopsy
- Thyroid Cancer Biopsy
Key Companies Covered in the Report:
- C. R. Bard, Inc.
- Becton, Dickinson and Company
- B. Braun Melsungen AG
- Cardinal Health, Inc.
- Olympus Corporation
- FUJIFILM Holdings Corporation
- Medtronic plc.
- Hologic, Inc
United States – Biopsy Testing Market – Overview
United States Biopsy Test Market was more than US$ 15 Billion in 2014 and future seems to be much brighter. In the United States Biopsy Test Market, Breast Cancer is the most popular segment in 2014. Thyroid cancer stands at the last spot, but it is the most rapidly increasing type of cancer in the United States. However if we make the analysis from the Volume point then Prostate Cancer is the most popular segment. Increasing United States prevalence of cancer, geriatric population and increasing demand for minimally invasive procedures are expected to drive market growth during the forecast period.
Place an Enquiry to Our Industry Expert at @ https://www.researchmoz.us/enquiry.php?type=E&repid=1572616
(*Fill the form and our sales representative will get back to you for assistance)
Latest Research report titled “United States – Biopsy Testing Market & Volume Analysis to 2020” provides a comprehensive assessment of the fast–evolving, high–growth of Biopsy Market. This 53 page report with 28 Figures and 1 Table analyses the United States Biopsy Test Market and Volume by 5 Top Cancer Segment, driving factors and challenges for Biopsy market.
The United States Biopsy Market has been analyzed from two view points
- United States Biopy Test Market & Forecast (2008 – 2020)
- United States Biopy Test Volume & Forecast (2008 – 2020)
The Top 5 Cancer Segments covered are:
- Breast Cancer
- Prostate Cancer
- Liver Cancer
- Lung Cancer
- Thyroid Cancer
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
For More Reports Visit @ http://marketresearchlatestreports.blogspot.com/
No comments:
Post a Comment